Skip to content

Study of "Aneurysmal spout area ratio" to guide the optimization in intracranial aneurysm endovascular embolization, a multi-center study

Study of "Aneurysmal spout area ratio" to guide the optimization in intracranial aneurysm endovascular embolization, a multi-center study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-15006570
Enrollment
Unknown
Registered
2015-04-11
Start date
2015-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial aneurysm

Interventions

Group C:coil embolization by utilizing the balloon-in-stent technique or double stents.
Group A:only coil embolization
Group B:stent/balloon assisted coil embolization

Sponsors

the First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80; 2. Intracranial aneurysms confirmed by CTA, MRA or DSA; 3. Diameter of parental artery >2mm; 4. The doctor consider that embolization with/without stent is an appropriate treatment; 5. Patients (or entrusted agent) willing to offer written informed consent; 6. Patients understand the purpose of this study and willing to coordinate clinical follow-up study.

Exclusion criteria

Exclusion criteria: 1. pseudoaneurysm?infected aneurysm or dissecting aneurysm; 2. Aneurysms were received craniotomy surgery treatment; 3. Hunt-Hess scale 4 or 5; 4. Patients with mRS score 4-5 or Glasgow Coma Scale less than eight points; 5. Serious parent artery vasospasm and the doctor consider that endovascular therapy is not an appropriate treatment; 6. Aneurysms associated with AVM, intracranial hematom has nothing to do with the aneurysm, brain tumor, serious parent artery stenosis, or moyamoya disease; 7. Pregnant and nursing women; 8. Patients participate in another clinical research (drug c) at the same time; 9. Patients who were not suitable for endovascular therapy due to iodine allergy; 10. Associated with other serious disease and survival time less than 1 year.

Design outcomes

Primary

MeasureTime frame
aneurysm location;defect area of intracranial aneurysm at parental artery;area of parental artery of the aneurysm located;Aneurysmal spout area ratio;proximal blood vessel diamete;distal blood vessel diamete;

Countries

China

Contacts

Public ContactHan Xin-Wei
hanxinwei2006@163.com+86 13803842129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026